drugset / Trial / NCT04177862

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

NCT04177862

Phase 4 Completed 75 enrolled University of Minnesota
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if a single dose of sublingual sufentanil is as or more efficacious than a single dose of IV fentanyl in a post anesthesia care setting.

Timeline

Start
2019-12-11
Primary completion
2020-01-31
Completion
2020-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 50 ug Intravenous
Subject Sufentanil Other / unclassified 30 ug Other

Indications

No indication recorded.